Development of ADC: Use of Model Systems for Understanding Mechanisms, Prioritization and Optimization of T-DXd and Combinations

Time: 2:00 pm
day: Applications for Efficacy Evaluation & Biomarker Discovery Day 2 PM


  • Evaluating the pros and cons of in vitro and in vivo models to facilitate preclinical to clinical translation
  • Delving into QSP models
  • Improving the ability to predict the efficacy and toxicity of ADCs